Pieris Pharmaceuticals, Inc. - Common Stock (NQ:PIRS)

13.60 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pieris Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team

August 03, 2021

- Tim Demuth, M.D., Ph.D., joins Pieris as Chief Medical Officer - Shane Olwill, Ph.D., promoted to Chief Development Officer BOSTON, MA / ACCESSWIRE / August 3, 2021 / Pieris Pharmaceuticals, Inc....

From Pieris Pharmaceuticals, Inc.

Via AccessWire

Pieris Pharmaceuticals to Host Second Quarter 2021 Investor Call and Provide Corporate Update on August 4, 2021

July 28, 2021

BOSTON, MA / ACCESSWIRE / July 28, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin®...

From Pieris Pharmaceuticals, Inc.

Via AccessWire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE

Via Benzinga

This Risky Micro-Cap Could Pay Off Big ↗

June 30, 2021

Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.

Via The Motley Fool

Pieris Stock Moves Higher On €14.2M Grant For PRS-220 In Post-COVID Pulmonary Fibrosis ↗

June 25, 2021

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) has announced the development of PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor to treat...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 25, 2021

Gainers Osmotica Pharmaceuticals (NASDAQ:OSMT) shares increased by 39.08% to $3.95 during Friday's pre-market session. The company's market cap stands at $247.7...

Via Benzinga

Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis

June 25, 2021

- PRS-220, an oral inhaled Anticalin protein targeting CTGF, a fully proprietary drug candidate for respiratory disease, is being developed as a local treatment for idiopathic pulmonary fibrosis -...

From Pieris Pharmaceuticals, Inc.

Via AccessWire

Topics Death

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs ↗

June 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

45 Biggest Movers From Yesterday ↗

June 25, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 24, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 27.11% to $4.5 during Thursday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

June 24, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne...

Via Benzinga

3 Top Stocks Under $10 ↗

June 24, 2021

Are you looking for cheap stocks with a lot of upside? Check out Rolls-Royce, Pieris Pharmaceuticals, and Kahoot!

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 24, 2021

Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...

Via Benzinga

Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer

June 24, 2021

BOSTON, MA / ACCESSWIRE / June 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin®...

From Pieris Pharmaceuticals, Inc.

Via AccessWire

21 Stocks Moving in Monday's Pre-Market Session ↗

June 21, 2021

Gainers Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V (NYSE: CNHI) announced plans to acquire Raven Industries for $58 per...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 02, 2021

Gainers Constellation (NASDAQ:CNST) shares moved upwards by 66.55% to $33.71 during Wednesday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 01, 2021

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

60 Biggest Movers From Yesterday ↗

May 28, 2021

Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 27, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 27, 2021

Gainers Rezolute (NASDAQ:RZLT) shares rose 46.68% to $11.28 during Thursday's regular session. As of 12:30 EST, Rezolute's stock is trading at a volume of 1.4...

Via Benzinga

41 Stocks Moving In Thursday's Mid-Day Session ↗

May 27, 2021

Gainers 1847 Goedeker Inc. (NYSE: GOED) shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday. Vertex Energy, Inc. (NASDAQ: VTNR) jumped 117% to $3.8604 after the...

Via Benzinga

PIRS Stock: The Big News That Has Pieris Pharma Shares Rising Today ↗

May 26, 2021

Pieris Pharmaceuticals (PIRS) stock is rising higher on Wednesday after announcing a collaboration agreement with Genentech.

Via InvestorPlace

Pieris Pharmaceuticals Surges On The Stock Market After Agreement With Genentech ↗

May 26, 2021

During yesterday's session, Pieris Pharmaceuticals (PIRS) soared in the financial markets after reaching a collaboration agreement with Genentech, in an operation that could be valued at $1.4 billion.

Via Talk Markets

Where Will The Pieris Pharmacuetical Stock Rally End? ↗

May 26, 2021

Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) on Tu...

Via Benzinga

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 25, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.